MV Capital Management’s GSK GSK Stock Holding History

MV Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.7K	Sell	56 -28	-33%	-$1.43K	﹤0.01%	754
2026 Q2	$4.4K	Sell	84 -6	-7%	-$317	﹤0.01%	667
2026 Q1	$4.97K	Buy	90 +69	+329%	+$3.74K	﹤0.01%	622
2025 Q4	$1.03K	Buy	+21	New	+$979	﹤0.01%	812
2022 Q4	–	Sell	-643	Closed	-$19K	–	677
2022 Q3	$19K	Hold	643	–	–	﹤0.01%	339
2022 Q2	$35K	Hold	643	–	–	0.01%	249
2022 Q1	$35K	Hold	643	–	–	0.01%	255
2021 Q4	$35K	Sell	643 -160	-20%	-$8.32K	0.01%	253
2021 Q3	$38K	Hold	803	–	–	0.01%	230
2021 Q2	$40K	Buy	803 +160	+25%	+$7.69K	0.01%	212
2021 Q1	$29K	Hold	643	–	–	0.01%	198
2020 Q4	$30K	Sell	643 -23	-3%	-$1.06K	0.01%	184
2020 Q3	$31K	Buy	666 +23	+4%	+$1.15K	0.01%	171
2020 Q2	$33K	Buy	+643	New	+$33K	0.01%	168
2019 Q4	–	Sell	-94	Closed	-$5K	–	380
2019 Q3	$5K	Buy	+94	New	+$4.84K	﹤0.01%	283
2017 Q4	–	Sell	-184	Closed	-$9K	–	369
2017 Q3	$9K	Hold	184	–	–	﹤0.01%	257
2017 Q2	$10K	Hold	184	–	–	﹤0.01%	249
2017 Q1	$10K	Hold	184	–	–	﹤0.01%	244
2016 Q4	$9K	Hold	184	–	–	﹤0.01%	241
2016 Q3	$10K	Hold	184	–	–	﹤0.01%	225
2016 Q2	$10K	Hold	184	–	–	﹤0.01%	224
2016 Q1	$9K	Hold	184	–	–	﹤0.01%	228
2015 Q4	$9K	Hold	184	–	–	﹤0.01%	240
2015 Q3	$9K	Hold	184	–	–	﹤0.01%	230
2015 Q2	$10K	Sell	184 -93	-34%	-$5.24K	﹤0.01%	302
2015 Q1	$16K	Buy	277 +213	+333%	+$12.2K	0.01%	252
2014 Q4	$3K	Buy	+64	New	+$3.58K	﹤0.01%	447

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

MV Capital Management's GSK Position: Q3 2026 in Review

MV Capital Management reduced its GSK (GSK) stake by 33% in Q3 2026, selling an estimated $1.43K and leaving 56 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #754.

MV Capital Management first reported a position in GSK in Q4 2014 and has held it in 27 quarters since. The position peaked at $40K in Q2 2021. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

MV Capital Management held 56 shares of GSK worth $2.7K as of Q3 2026.
MV Capital Management sold 28 GSK shares in Q3 2026, an estimated $1.43K.
GSK made up ﹤0.01% of MV Capital Management's portfolio in Q3 2026, its #754 holding.
MV Capital Management first reported a position in GSK in Q4 2014 and has held it in 27 quarters since.
MV Capital Management's GSK position peaked at $40K in Q2 2021.
654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.